Tsann-Long Su

814 total citations
22 papers, 733 citations indexed

About

Tsann-Long Su is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Tsann-Long Su has authored 22 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Organic Chemistry and 7 papers in Toxicology. Recurrent topics in Tsann-Long Su's work include Cancer therapeutics and mechanisms (13 papers), Synthesis and Biological Evaluation (9 papers) and Bioactive Compounds and Antitumor Agents (7 papers). Tsann-Long Su is often cited by papers focused on Cancer therapeutics and mechanisms (13 papers), Synthesis and Biological Evaluation (9 papers) and Bioactive Compounds and Antitumor Agents (7 papers). Tsann-Long Su collaborates with scholars based in Taiwan, United States and India. Tsann-Long Su's co-authors include Ting‐Chao Chou, Te‐Chang Lee, Rajesh Kakadiya, Anamik Shah, Huajin Dong, Xiu-Guo Zhang, Pei‐Chih Lee, Tian-Shung Wu, Naval Kapuriya and Tung‐Hu Tsai and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Biochemical Pharmacology.

In The Last Decade

Tsann-Long Su

22 papers receiving 709 citations

Peers

Tsann-Long Su
Matthew G. LaPorte United States
Zhao‐Kui Wan United States
Jayoung Song South Korea
J. Adam Willardsen United States
Paul M. Scola United States
Yu Luo China
Weixin Xu United States
Tsann-Long Su
Citations per year, relative to Tsann-Long Su Tsann-Long Su (= 1×) peers Chun Sing Li

Countries citing papers authored by Tsann-Long Su

Since Specialization
Citations

This map shows the geographic impact of Tsann-Long Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsann-Long Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsann-Long Su more than expected).

Fields of papers citing papers by Tsann-Long Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsann-Long Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsann-Long Su. The network helps show where Tsann-Long Su may publish in the future.

Co-authorship network of co-authors of Tsann-Long Su

This figure shows the co-authorship network connecting the top 25 collaborators of Tsann-Long Su. A scholar is included among the top collaborators of Tsann-Long Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsann-Long Su. Tsann-Long Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Chi‐Wei, Yi‐Fan Chen, Yi‐Wen Lin, et al.. (2016). A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells. Neoplasia. 18(4). 199–212. 18 indexed citations
2.
Yen, Jiin‐Cherng, et al.. (2013). Determination of tissue distribution of potent antitumor agent ureidomustin (BO-1055) by HPLC and its pharmacokinetic application in rats. Journal of Chromatography B. 917-918. 62–70. 5 indexed citations
3.
Chen, Chi‐Wei, Pei‐Chih Lee, Rajesh Kakadiya, et al.. (2012). Synthesis and antitumor evaluation of novel Benzo[d]pyrrolo[2,1-b]thiazole derivatives. European Journal of Medicinal Chemistry. 53. 28–40. 34 indexed citations
4.
Lo, Wen‐Liang, Pen‐Yuan Chu, Tsann-Long Su, et al.. (2012). A Combined DNA-Affinic Molecule and N-Mustard Alkylating Agent Has an Anti-Cancer Effect and Induces Autophagy in Oral Cancer Cells. International Journal of Molecular Sciences. 13(3). 3277–3290. 7 indexed citations
5.
Chu, Pei-Ming, Shih‐Hwa Chiou, Tsann-Long Su, et al.. (2011). Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response. Radiation Oncology. 6(1). 7–7. 20 indexed citations
6.
Lee, Pei‐Chih, Huajin Dong, Rajesh Kakadiya, et al.. (2011). Design, synthesis and antitumor evaluation of phenyl N-mustard-quinazoline conjugates. Bioorganic & Medicinal Chemistry. 19(6). 1987–1998. 87 indexed citations
7.
Chu, Pei-Ming, Li-Hsin Chen, Ming-Teh Chen, et al.. (2011). Targeting autophagy enhances BO-1051-induced apoptosis in human malignant glioma cells. Cancer Chemotherapy and Pharmacology. 69(3). 621–633. 18 indexed citations
8.
Kapuriya, Naval, Rajesh Kakadiya, Huajin Dong, et al.. (2010). Design, synthesis, and biological evaluation of novel water-soluble N-mustards as potential anticancer agents. Bioorganic & Medicinal Chemistry. 19(1). 471–485. 27 indexed citations
9.
Chen, Li-Hsin, Che-Chuan Loong, Tsann-Long Su, et al.. (2010). Autophagy inhibition enhances apoptosis triggered by BO-1051, an N-mustard derivative, and involves the ATM signaling pathway. Biochemical Pharmacology. 81(5). 594–605. 44 indexed citations
10.
Kapuriya, Naval, Huajin Dong, Pei‐Chih Lee, et al.. (2010). Novel bifunctional alkylating agents, 5,10-dihydropyrrolo[1,2-b]isoquinoline derivatives, synthesis and biological activity. Bioorganic & Medicinal Chemistry. 19(1). 275–286. 20 indexed citations
11.
Lee, Pei‐Chih, Rajesh Kakadiya, Tsann-Long Su, & Te‐Chang Lee. (2010). Combination of Bifunctional Alkylating Agent and Arsenic Trioxide Synergistically Suppresses the Growth of Drug-Resistant Tumor Cells. Neoplasia. 12(5). 376–IN2. 30 indexed citations
12.
Kakadiya, Rajesh, Huajin Dong, Pei‐Chih Lee, et al.. (2009). Potent antitumor bifunctional DNA alkylating agents, synthesis and biological activities of 3a-aza-cyclopenta[a]indenes. Bioorganic & Medicinal Chemistry. 17(15). 5614–5626. 55 indexed citations
13.
Kapuriya, Naval, Xiu-Guo Zhang, Ting‐Chao Chou, et al.. (2008). Synthesis and biological activity of stable and potent antitumor agents, aniline nitrogen mustards linked to 9-anilinoacridines via a urea linkage. Bioorganic & Medicinal Chemistry. 16(10). 5413–5423. 58 indexed citations
14.
Kapuriya, Naval, Huajin Dong, Xiu-Guo Zhang, et al.. (2008). Novel DNA-directed alkylating agents: Design, synthesis and potent antitumor effect of phenyl N-mustard-9-anilinoacridine conjugates via a carbamate or carbonate linker. Bioorganic & Medicinal Chemistry. 17(3). 1264–1275. 22 indexed citations
15.
Su, Tsann-Long, et al.. (2006). Potent Antitumor 9-Anilinoacridines and Acridines Bearing an Alkylating N-Mustard Residue on the Acridine Chromophore:  Synthesis and Biological Activity. Journal of Medicinal Chemistry. 49(12). 3710–3718. 43 indexed citations
16.
Chou, Ting‐Chao, et al.. (2005). Potent antitumor 9-anilinoacridines bearing an alkylating N-mustard residue on the anilino ring: synthesis and biological activity. Bioorganic & Medicinal Chemistry. 13(12). 3993–4006. 32 indexed citations
17.
Chang, Jang‐Yang, Yi‐Wen Lin, Wen-Yu Pan, et al.. (2005). Synthesis and antitumor activity of 5-(9-acridinylamino)anisidine derivatives. Bioorganic & Medicinal Chemistry. 13(23). 6513–6520. 30 indexed citations
18.
Chang, Jang‐Yang, Wen-Yu Pan, Ting‐Chao Chou, et al.. (2003). New analogues of AHMA as potential antitumor agents: synthesis and biological activity. Bioorganic & Medicinal Chemistry. 11(23). 4959–4969. 23 indexed citations
19.
Chang, Jang‐Yang, et al.. (2002). Antitumor AHMA Linked to DNA Minor Groove Binding Agents:  Synthesis and Biological Evaluation. Journal of Medicinal Chemistry. 45(20). 4485–4493. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026